193 related articles for article (PubMed ID: 36415096)
1. Role of Flavonoids in Management of Various Biological Targets in Alzheimer's Disease: Evidence from Preclinical to Clinical Studies.
Alharbi KS; Javed Shaikh MA; Imam SS; Alshehri S; Ghoneim MM; Almalki WH; Singh SK; Kumar D; Kumar AP; Dua K; Chellappan DK; Paudel KR; Gupta G
Curr Med Chem; 2023; 30(18):2061-2074. PubMed ID: 36415096
[TBL] [Abstract][Full Text] [Related]
2. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
3. Flavonoid-rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 transgenic mice.
Ma Y; Ma B; Shang Y; Yin Q; Hong Y; Xu S; Shen C; Hou X; Liu X
Brain Res; 2018 Jan; 1678():85-93. PubMed ID: 29038004
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of flavonoids in the management of obesity-induced Alzheimer's disease: an overview of preclinical and clinical studies.
Kothawade SM; Buttar HS; Tuli HS; Kaur G
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2813-2830. PubMed ID: 37231172
[TBL] [Abstract][Full Text] [Related]
5. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
Gugliandolo A; Bramanti P; Mazzon E
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
[TBL] [Abstract][Full Text] [Related]
6. Role of Withaferin A and Its Derivatives in the Management of Alzheimer's Disease: Recent Trends and Future Perspectives.
Das R; Rauf A; Akhter S; Islam MN; Emran TB; Mitra S; Khan IN; Mubarak MS
Molecules; 2021 Jun; 26(12):. PubMed ID: 34204308
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid β and Tau Protein.
Parums DV
Med Sci Monit; 2021 Jul; 27():e934077. PubMed ID: 34305135
[TBL] [Abstract][Full Text] [Related]
8. Flavonoids and Polyphenolic Compounds as Potential Talented Agents for the Treatment of Alzheimer's Disease and their Antioxidant Activities.
Akter R; Chowdhury MAR; Rahman MH
Curr Pharm Des; 2021; 27(3):345-356. PubMed ID: 33138754
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.
Baptista FI; Henriques AG; Silva AM; Wiltfang J; da Cruz e Silva OA
ACS Chem Neurosci; 2014 Feb; 5(2):83-92. PubMed ID: 24328060
[TBL] [Abstract][Full Text] [Related]
10. Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids.
Pluta R; Miziak B; Czuczwar SJ
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570596
[TBL] [Abstract][Full Text] [Related]
11. Role of natural products for the treatment of Alzheimer's disease.
Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Flavonoids against Alzheimer's Disease: Pathological Hypothesis, Potential Targets, and Structure-Activity Relationship.
Li J; Sun M; Cui X; Li C
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077418
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
14. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
15. The Neuroprotective Potentiality of Flavonoids on Alzheimer's Disease.
Calderaro A; Patanè GT; Tellone E; Barreca D; Ficarra S; Misiti F; Laganà G
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499159
[TBL] [Abstract][Full Text] [Related]
16. Isobavachalcone ameliorates cognitive deficits, and Aβ and tau pathologies in triple-transgenic mice with Alzheimer's disease.
Zhang M; Wu Q; Zhao R; Yao X; Du X; Liu Q; Lv G; Xiao S
Food Funct; 2021 Sep; 12(17):7749-7761. PubMed ID: 34269361
[TBL] [Abstract][Full Text] [Related]
17. Flavanol-rich lychee fruit extract substantially reduces progressive cognitive and molecular deficits in a triple-transgenic animal model of Alzheimer disease.
Chen X; Xu B; Nie L; He K; Zhou L; Huang X; Spencer P; Yang X; Liu J
Nutr Neurosci; 2021 Sep; 24(9):720-734. PubMed ID: 31603034
[TBL] [Abstract][Full Text] [Related]
18. Saponins and flavonoids from Bacopa floribunda plant extract exhibit antioxidant and anti-inflammatory effects on amyloid beta 1-42-induced Alzheimer's disease in BALB/c mice.
Oyeleke MB; Owoyele BV
J Ethnopharmacol; 2022 Apr; 288():114997. PubMed ID: 35033624
[TBL] [Abstract][Full Text] [Related]
19. Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.
Saeedi M; Rashidy-Pour A
Biomed Pharmacother; 2021 Jan; 133():110995. PubMed ID: 33232931
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease.
Kumar K; Kumar A; Keegan RM; Deshmukh R
Biomed Pharmacother; 2018 Feb; 98():297-307. PubMed ID: 29274586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
